Hematology Oncology Pharmacy Association Inc
Hematology Oncology Pharmacy Association shows strong financial growth and zero reported officer compensation over a decade.
EIN: 201044674 · Milwaukee, WI · NTEE: G30 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $10.9M |
| Total Expenses | $6.1M |
| Program Spending | 90% |
| Net Assets | $8.0M |
| Transparency Score | 95/100 |
Is Hematology Oncology Pharmacy Association Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Hematology Oncology Pharmacy Association Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Hematology Oncology Pharmacy Association Inc
Hematology Oncology Pharmacy Association Inc (EIN: 201044674) is a nonprofit organization based in Milwaukee, WI, classified under NTEE code G30. The organization reported total revenue of $10.9M and total assets of $10.0M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Hematology Oncology Pharmacy Association Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Hematology Oncology Pharmacy Association Inc is a large nonprofit that has been operating for 22 years, with 14 years of IRS 990 filings on record (2010–2023). Revenue has grown at a compound annual rate of 7.1%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $6.5M |
| Total Expenses | $6.1M |
| Surplus / Deficit | +$328K |
| Total Assets | $10.2M |
| Total Liabilities | $2.2M |
| Net Assets | $8.0M |
| Operating Margin | 5.1% |
| Debt-to-Asset Ratio | 21.9% |
| Months of Reserves | 20.0 months |
Financial Health Grade: A
In 2023, Hematology Oncology Pharmacy Association Inc reported a surplus of $328K with revenue exceeding expenses, holds 20.0 months of operating reserves (strong position), has a debt-to-asset ratio of 21.9% (moderate leverage).
Financial Trends
Over 14 years of filings (2010–2023), Hematology Oncology Pharmacy Association Inc's revenue has grown at a compound annual growth rate (CAGR) of 7.1%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +15.3% | +10.8% | +23.4% |
| 2022 | +1.2% | +52.8% | -7.5% |
| 2021 | -3.2% | -29.7% | +19.4% |
| 2020 | +7.8% | +0.2% | -9.3% |
| 2019 | +3.3% | +8.6% | +21.7% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2004 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Hematology Oncology Pharmacy Association Inc with a Mission Score of 95 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 7%
- programs: 90%
- fundraising: 3%
According to IRS 990 filings, Hematology Oncology Pharmacy Association Inc allocates its expenses as follows: admin: 7%, programs: 90%, fundraising: 3%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $328K, with revenue exceeding expenses.
- Debt-to-asset ratio: 21.9%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, indicating that no salaries are paid to officers, or that such compensation is not reported in this section of the 990, which is highly unusual for an organization of this size and revenue. This suggests either a volunteer leadership model or that compensation is categorized differently, warranting further investigation for complete transparency.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Hematology Oncology Pharmacy Association Inc's IRS 990 filings:
- Zero reported officer compensation for an organization with over $10 million in revenue could indicate compensation is reported elsewhere or a highly unusual volunteer leadership structure, warranting further scrutiny for full transparency.
Strengths
The following positive indicators were identified for Hematology Oncology Pharmacy Association Inc:
- Consistent and significant revenue growth over the past decade, from $2.6M in 2014 to over $10M currently.
- Strong asset accumulation, growing from $4M in 2014 to over $10M in 2023, indicating financial stability.
- Expenses consistently below revenue, allowing for healthy surpluses and asset growth.
- Zero reported officer compensation across all filings, suggesting a strong commitment to mission-focused spending or volunteer leadership.
- Manageable liabilities relative to assets, indicating sound financial management.
Frequently Asked Questions about Hematology Oncology Pharmacy Association Inc
Is Hematology Oncology Pharmacy Association Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Hematology Oncology Pharmacy Association Inc (EIN: 201044674) some concerns. Mission Score: 95/100. 1 red flag identified, 5 strengths noted.
How does Hematology Oncology Pharmacy Association Inc spend its money?
Hematology Oncology Pharmacy Association Inc directs 90% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Hematology Oncology Pharmacy Association Inc tax-deductible?
Hematology Oncology Pharmacy Association Inc is registered as a tax-exempt nonprofit (EIN: 201044674). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Hematology Oncology Pharmacy Association Inc's spending goes to programs?
Hematology Oncology Pharmacy Association Inc directs 90% to programs, 3% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Hematology Oncology Pharmacy Association Inc compare to similar nonprofits?
With a transparency score of 95/100 (Excellent), Hematology Oncology Pharmacy Association Inc is above average for NTEE category G30 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Hematology Oncology Pharmacy Association Inc located?
Hematology Oncology Pharmacy Association Inc is headquartered in Milwaukee, Wisconsin and files with the IRS under EIN 201044674. It is classified under NTEE code G30.
How many years of IRS 990 filings does Hematology Oncology Pharmacy Association Inc have?
Hematology Oncology Pharmacy Association Inc has 14 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $10.9M in total revenue.
Is Hematology Oncology Pharmacy Association Inc a good charity?
Based on its strong financial health, consistent revenue growth, significant asset accumulation, and zero reported officer compensation, HOPA appears to be a very well-managed organization. Its financial stability and apparent dedication to its mission without high executive salaries are positive indicators.
How has HOPA's revenue grown over the past decade?
HOPA has shown substantial revenue growth, increasing from $2,680,418 in 2014 to $6,458,020 in 2023, and a latest reported revenue of $10,868,978, demonstrating a significant upward trend.
What is the trend in HOPA's assets?
HOPA's assets have consistently grown, from $4,085,372 in 2014 to $10,206,492 in 2023, indicating strong financial accumulation and stability.
Filing History
IRS 990 filing history for Hematology Oncology Pharmacy Association Inc showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2010–2023), Hematology Oncology Pharmacy Association Inc's revenue has grown by 142.5%, moving from $2.7M to $6.5M. Total assets increased by 242.8% over the same period, from $3.0M to $10.2M. Total functional expenses rose by 147.9%, from $2.5M to $6.1M. In its most recent filing year (2023), Hematology Oncology Pharmacy Association Inc reported a surplus of $328K, with revenue exceeding expenses. The organization holds $2.2M in liabilities against $10.2M in assets (debt-to-asset ratio: 21.9%), resulting in net assets of $8.0M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $6.5M | $6.1M | $10.2M | $2.2M | — | View 990 |
| 2022 | $5.6M | $5.5M | $8.3M | $1.1M | — | View 990 |
| 2021 | $5.5M | $3.6M | $8.9M | $952K | — | View 990 |
| 2020 | $5.7M | $5.1M | $7.5M | $843K | — | View 990 |
| 2019 | $5.3M | $5.1M | $8.3M | $2.6M | — | View 990 |
| 2018 | $5.1M | $4.7M | $6.8M | $1.8M | — | View 990 |
| 2017 | $4.4M | $3.7M | $6.9M | $1.9M | — | View 990 |
| 2016 | $3.8M | $3.1M | $5.8M | $1.8M | — | View 990 |
| 2015 | $2.9M | $2.7M | $5.0M | $1.8M | — | View 990 |
| 2014 | $2.7M | $2.5M | $4.1M | $1.0M | — | View 990 |
| 2013 | $2.1M | $2.0M | $3.7M | $792K | — | View 990 |
| 2012 | $2.1M | $1.9M | $3.4M | $632K | — | View 990 |
| 2011 | $1.8M | $1.6M | $3.3M | $702K | — | View 990 |
| 2010 | $2.7M | $2.5M | $3.0M | $579K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $6.5M, expenses of $6.1M, and assets of $10.2M (revenue +15.3% year-over-year).
- 2022: Revenue of $5.6M, expenses of $5.5M, and assets of $8.3M (revenue +1.2% year-over-year).
- 2021: Revenue of $5.5M, expenses of $3.6M, and assets of $8.9M (revenue -3.2% year-over-year).
- 2020: Revenue of $5.7M, expenses of $5.1M, and assets of $7.5M (revenue +7.8% year-over-year).
- 2019: Revenue of $5.3M, expenses of $5.1M, and assets of $8.3M (revenue +3.3% year-over-year).
- 2018: Revenue of $5.1M, expenses of $4.7M, and assets of $6.8M (revenue +17.3% year-over-year).
- 2017: Revenue of $4.4M, expenses of $3.7M, and assets of $6.9M (revenue +16.1% year-over-year).
- 2016: Revenue of $3.8M, expenses of $3.1M, and assets of $5.8M (revenue +31.5% year-over-year).
- 2015: Revenue of $2.9M, expenses of $2.7M, and assets of $5.0M (revenue +6.9% year-over-year).
- 2014: Revenue of $2.7M, expenses of $2.5M, and assets of $4.1M (revenue +27.4% year-over-year).
- 2013: Revenue of $2.1M, expenses of $2.0M, and assets of $3.7M (revenue +2.4% year-over-year).
- 2012: Revenue of $2.1M, expenses of $1.9M, and assets of $3.4M (revenue +13.6% year-over-year).
- 2011: Revenue of $1.8M, expenses of $1.6M, and assets of $3.3M (revenue -32.0% year-over-year).
- 2010: Revenue of $2.7M, expenses of $2.5M, and assets of $3.0M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Hematology Oncology Pharmacy Association Inc:
Data Sources and Methodology
This transparency report for Hematology Oncology Pharmacy Association Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.